Cerity Partners’s OKYO Pharma OKYO Stock Holding History

Cerity Partners’s Portfolio OKYO Stock Details OKYO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$19.2K	Hold	12,812	–	–	﹤0.01%	3366
2026 Q1	$20.6K	Hold	12,812	–	–	﹤0.01%	3181
2025 Q4	$26.5K	Hold	12,812	–	–	﹤0.01%	2835
2025 Q3	$25.6K	Hold	12,812	–	–	﹤0.01%	2717
2025 Q2	$32.9K	Hold	12,812	–	–	﹤0.01%	2580
2025 Q1	$16.3K	Hold	12,812	–	–	﹤0.01%	2453
2024 Q4	$14.7K	Hold	12,812	–	–	﹤0.01%	2407
2024 Q3	$13.1K	Hold	12,812	–	–	﹤0.01%	2516
2024 Q2	$15.2K	Sell	12,812 -500	-4%	-$700	﹤0.01%	2208
2024 Q1	$19.8K	Buy	13,312 +1,000	+8%	+$1.54K	﹤0.01%	2272
2023 Q4	$21.8K	Buy	+12,312	New	+$21.6K	﹤0.01%	1835

Other funds holding OKYO

Woodline Partners San Francisco, California $32.4B AUM 58.5% 1-Year Est. Return

SCM

Stonepine Capital Management Bend, Oregon $177M AUM 91.13% 1-Year Est. Return

Maven Securities St Helier, Jersey $5.06B AUM 59.27% 1-Year Est. Return

Balyasny Asset Management Chicago, Illinois $80.2B AUM 51.53% 1-Year Est. Return

Opaleye Management Boston, Massachusetts $1.1B AUM 197.64% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

XTX Topco George Town, Cayman Islands $7.72B AUM 32.88% 1-Year Est. Return

Choreo LLC Rockford, Illinois $9.11B AUM 26.3% 1-Year Est. Return

QCM

Quantinno Capital Management New York $83.3B AUM 37.97% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Cerity Partners's OKYO Position: Q2 2026 in Review

Cerity Partners held its OKYO Pharma (OKYO) position steady in Q2 2026 at 12,812 shares worth $19.2K. The position accounts for ﹤0.01% of the portfolio, ranked #3366.

Cerity Partners first reported a position in OKYO in Q4 2023 and has held it in 11 quarters since. The position peaked at $32.9K in Q2 2025. 19 funds tracked by Wall St. Rank hold OKYO as of Q2 2026.

Cerity Partners held 12,812 shares of OKYO Pharma worth $19.2K as of Q2 2026.
Cerity Partners left its OKYO Pharma share count unchanged in Q2 2026.
OKYO Pharma made up ﹤0.01% of Cerity Partners's portfolio in Q2 2026, its #3366 holding.
Cerity Partners first reported a position in OKYO Pharma in Q4 2023 and has held it in 11 quarters since.
Cerity Partners's OKYO Pharma position peaked at $32.9K in Q2 2025.
19 funds tracked by Wall St. Rank held OKYO Pharma as of Q2 2026.

Based on Cerity Partners's 13F filing for Q2 2026, filed 14 Aug 2026.